Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency
- PMID: 6381059
- DOI: 10.1007/BF00445602
Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency
Abstract
In a 3-year-old mentally retarded girl with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency among different therapeutic approaches only treatment with betaine (15-20 g/day) resulted in a satisfactory biochemical response. Betaine improved homocysteine remethylation and thus lowered plasma homocystine to trace amounts and normalized the previously very low plasma methionine concentration. This biochemical response was associated with a clinical improvement although she remained mentally retarded.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical